Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Items 601–700 of 1,033
Frank, C. F., & Hostetter, M. K. (2007) · Translational research · doi:10.1016/j.trsl.2006.11.006 · Cited by 97
The prevention, diagnosis and management of central venous line infections in children
Chesshyre, E. L. D., Goff, Z., Bowen, A. C., & Carapetis, J. R. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.04.029 · Cited by 97
Update on Oral Fungal Infections
Muzyka, B. C., & Epifanio, R. N. (2013) · Dental Clinics of North America · doi:10.1016/j.cden.2013.07.002 · Cited by 99
Pathogenesis of invasive candidiasis
van de Veerdonk, F. L., Kullberg, B.-J., & Netea, M. G. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e046e · Cited by 88
Zhang, S. X., Babady, N. E., Hanson, K. E., Harrington, A., Larkin, P. M. K., Leal, S. M., Luethy, P. M., Martin, I. W., Pancholi, P., Procop, G. W., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01784-20 · Cited by 90
An overview of antifungal peptides derived from insect
Faruck, M. O., Yusof, F., & Chowdhury, S. (2015) · Peptides · doi:10.1016/j.peptides.2015.06.001 · Cited by 96
Qadri, S. M., Donkor, D. A., Bhakta, V., Eltringham‐Smith, L. J., Dwivedi, D. J., Moore, J. C., Pepler, L., Ivetic, N., Nazi, I., Fox‐Robichaud, A., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12778 · Cited by 88
“aeruginosa is also a primary cause of sepsis and mortality in immunocompromised individuals [3, 4].”
BackgroundBeganovic, M., Costello, M., & Wieczorkiewicz, S. M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02245-16 · Cited by 90
Mgbeahuruike, E. E., Stålnacke, M., Vuorela, H. J., & Holm, Y. (2019) · Antibiotics · doi:10.3390/antibiotics8020055 · Cited by 93
Management and prevention of drug resistant infections in burn patients
Vinaik, R., Barayan, D., Shahrokhi, S., & Jeschke, M. G. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1648208 · Cited by 99
“linked to higher mortality independent of the size of burn surface area, patient age, and other critical factors [55].”
BackgroundJaeger, M., van der Lee, R., Cheng, S.-C., Johnson, M. D., Kumar, V., Ng, A., Plantinga, T. S., Smeekens, S. P., Oosting, M., Wang, X., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2309-2 · Cited by 86
Molecular Epidemiology of Enterococcal Bacteremia in Australia
Coombs, G. W., Pearson, J. C., Daley, D. A., Le, T., Robinson, J. O., Gottlieb, T., Howden, B. P., Johnson, P. D. R., Bennett, C. M., Stinear, T. P., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03286-13 · Cited by 89
“Similar to the situation in the United States (25) and in Europe (26), in Australia enterococcal bacteremia, and notably bacteremia caused by multidrug-resistant E.”
ResultInfluentialDevelopments for improved diagnosis of bacterial bloodstream infections
Loonen, A. J. M., Wolffs, P. F. G., Bruggeman, C. A., & van den Brule, A. J. C. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2153-4 · Cited by 88
“One of the largest multicenter studies found that hospital acquired (nosocomial) BSI is in 65 % of the cases a result of Grampositive bacteria, in 25 % Gram-negative bacteria are found, and 10 % of BSI cases are caused by fungi [19].”
BackgroundChalupka, A. N., & Talmor, D. S. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2011.09.003 · Cited by 107
Rio, A. D., Gasch, O., Moreno, A., Pena, C., Cuquet, J., Soy, D., Mestres, C. A., Suarez, C., Paré, J. C., Tubau, F., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu580 · Cited by 94
“most European countries are resistant to methicillin [1, 2].”
BackgroundBhattacharjee, P. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.5 · Cited by 121
“In spite of advances in the diagnosis and treatment of candidiasis, among the pathogens involved in BSI, Candida ranks fourth in the United States and seventh in Europe [3-6].”
BackgroundInfluentialAzole Resistance in Candida glabrata
Whaley, S. G., & Rogers, P. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0554-5 · Cited by 85
Pathogenic factors in Candida biofilm-related infectious diseases
Hirota, K., Yumoto, H., Sapaar, B., Matsuo, T., Ichikawa, T., & Miyake, Y. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13330 · Cited by 83
“albicans are also the second and fourth most common cause of bloodstream infections, respectively (Wisplinghoff et al. 2004).”
BackgroundIdentification of Novel Bacteriophages with Therapeutic Potential That Target Enterococcus faecalis
Al-Zubidi, M., Widziołek, M., Court, E. K., Gains, A. F., Smith, R. E., Ansbro, K., Alrafaie, A. M., Evans, C. A., Murdoch, C., Mesnage, S., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00512-19 · Cited by 92
“Enterococcus faecalis is a common nosocomial pathogen that is frequently isolated from the bloodstream and wound infections (1, 2).”
Sanchez, D. A., Schairer, D. O., Tuckman-Vernon, C., Chouake, J. S., Kutner, A. J., Makdisi, J., Friedman, J. M., Nosanchuk, J. D., & Friedman, A. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.06.002 · Cited by 93
Ghanem, G., Boktour, M. R., Warneke, C. L., Pham-Williams, T., Kassis, C., Bahna, P., Aboufaycal, H., Hachem, R. Y., & RAAD, I. I. (2007) · Medicine · doi:10.1097/md.0b013e318030d344 · Cited by 97
Invasive Candidiasis: An Overview from Taiwan
Ruan, S., & Hsueh, P. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60091-7 · Cited by 96
Cerca, N., Maira‐Litrán, T., Jefferson, K. K., Grout, M., Goldmann, D. A., & Pier, G. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700630104 · Cited by 97
Seifert, H., Aurbach, U., Stefanik, D., & Cornely, O. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01217-06 · Cited by 84
“Over the past two decades, the incidence of Candida bloodstream infections has increased dramatically (3, 15), primarily due to the increase in the number of at-risk patients.”
BackgroundSelf-citationPaiva, J.-A., Pereira, J. M., Tabah, A., Mikstacki, A., de Carvalho, F. B., Koulenti, D., Ruckly, S., Çakar, N., Misset, B., Dimopoulos, G., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1229-1 · Cited by 84
Mendes, R. E., Castanheira, M., Farrell, D. J., Flamm, R. K., Sader, H. S., & Jones, R. N. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw319 · Cited by 87
Casey, A. L., Lambert, P. A., & Elliott, T. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(07)72175-1 · Cited by 133
Gebert, S., Siegel, D., & Wellinghausen, N. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.07.013 · Cited by 94
Salgado-Pabón, W., Herrera, A., Vu, B. G., Stach, C. S., Merriman, J. A., Spaulding, A. R., & Schlievert, P. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu146 · Cited by 83
“fective endocarditis, septicemia, and many other common infections [2–7].”
BackgroundHolloway, K. P., Rouphael, N., Wells, J. B., King, M. D., & Blumberg, H. M. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h353 · Cited by 84
Antifungal Nanoparticles and Surfaces
Paulo, C. S. O., Vidal, M., & Ferreira, L. S. (2010) · Biomacromolecules · doi:10.1021/bm100893r · Cited by 84
Niven, D. J., & Laupland, K. B. (2016) · Critical Care · doi:10.1186/s13054-016-1406-2 · Cited by 101
“aureus, enterococcal species, and Gram-negative Enterobacteriaceae [42, 43].”
InfluentialRecent Advances on Electrochemical Biosensing Strategies toward Universal Point‐of‐Care Systems
Dai, Y., & Liu, C.-C. (2019) · Angewandte Chemie · doi:10.1002/ange.201901879 · Cited by 91
Sepsis: From Pathophysiology to Individualized Patient Care
László, I., Trásy, D., Molnár, Z., & Fazakas, J. (2015) · Journal of Immunology Research · doi:10.1155/2015/510436 · Cited by 103
“commonly isolated microorganism in the bloodstream of ICU patients and its associated mortality is reported to be as high as 40–60% [67, 68].”
BackgroundFreixas, N., Bella, F., Limón, E., Pujol, M., Almirante, B., & Gudiol, F. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12049 · Cited by 102
Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremia
Mora-Rillo, M., Fernández-Romero, N., Francisco, C. N.-S., Díez‐Sebastián, J., Romero‐Gómez, M. P., Arnalich, F., Arribas, J. R., & Mingorance, J. (2015) · Virulence · doi:10.4161/21505594.2014.991234 · Cited by 105
“Escherichia coli is the gram-negative organism most frequently isolated in adult patients with bacteremia.(1,2) Though it is a commensal of the normal intestinal microbiota of mammals and birds,(3) some strains of E.”
BackgroundRodriguez-Suarez, R. J., Xu, D., Veillette, K., Davison, J., Sillaots, S., Kauffman, S., Hu, W., Bowman, J. C., Martel, N., Trosok, S., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.09.009 · Cited by 86
Hermsen, E. D., Zapapas, M. K., Maiefski, M., Rupp, M. E., Freifeld, A. G., & Kalil, A. C. (2011) · Critical Care · doi:10.1186/cc10366 · Cited by 82
“Due to the appreciable morbidity, mortality and costs associated with invasive candidiasis and the implications of delayed appropriate antifungal therapy, the use of clinical prediction rules to help determine in which high-risk patients prophylactic antifungal therapy may be beneficial is of interest [2,4-7].”
BackgroundQu, Y., Locock, K. E. S., Verma‐Gaur, J., Hay, I. D., Meagher, L., & Traven, A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv334 · Cited by 84
Mera, R. M., Miller, L. A., Amrine‐Madsen, H., & Sahm, D. F. (2010) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0052 · Cited by 85
“28 Although most of the patients had respiratory tract infections, a minority had bacteremia with an unknown primary site.”
Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
Kim, U. J., Kim, H. K., An, J. H., Cho, S. K., Park, K., & Jang, H. (2014) · Chonnam Medical Journal · doi:10.4068/cmj.2014.50.2.37 · Cited by 119
“baumannii account for 1% to 2% of all nosocomial bloodstream infections.(27,28) A.”
BackgroundRisk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections
Lee, I., Fishman, N. O., Zaoutis, T. E., Morales, K. H., Weiner, M. G., Synnestvedt, M., Nachamkin, I., & Lautenbach, E. (2009) · Archives of Internal Medicine · doi:10.1001/archinte.169.4.379 · Cited by 81
Gardner, A., MITCHELL, B. G., Beckingham, W. D., & Fasugba, O. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005099 · Cited by 83
Drug Treatment for Multidrug-Resistant Acinetobacter Baumannii Infections
Bassetti, M., Righi, E., Esposito, S., Petrosillo, N., & Nicolini, L. A. (2008) · Future Microbiology · doi:10.2217/17460913.3.6.649 · Cited by 84
Sweet, M. A., Cumpston, A., Briggs, F., Craig, M., & Hamadani, M. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.01.025 · Cited by 96
Wu, C., Lee, H., Lee, N., Shih, H., Ko, N., Wang, L., & Ko, W. (2006) · PubMed · Cited by 82
Efficacy and safety of amphotericin B lipid‐based formulations—A systematic review and meta‐analysis
Steimbach, L. M., Tonin, F. S., Virtuoso, S., Borba, H. H. L., Sanches, A. C. C., Wiens, A., Fernández-Llimós, F., & Pontarolo, R. (2016) · Mycoses · doi:10.1111/myc.12585 · Cited by 95
Candidaemia in internal medicine departments: the burden of a rising problem
Bassetti, M., Molinari, M. P., Mussap, M., Viscoli, C., & Righi, E. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12155 · Cited by 89
“The incidence of candidaemia in tertiary care hospitals worldwide has increased substantially over recent decades [1–3] due to the increasing complexity of surgical procedures, the existence of patient populations at higher risk of infection, and the changes in patient demographic characteristics.”
BackgroundNutman, A., Glick, R., Temkin, E., Hoshen, M., Edgar, R., Braun, T., & Carmeli, Y. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12716 · Cited by 85
“baumannii bacteraemia ranges widely from 30 to 52%, which is comparable to other Gram-negative bacteria [20,21].”
BackgroundComparative genomics of Enterococcus faecalis from healthy Norwegian infants
Solheim, M., Aakra, Å., Snipen, L. G., Brede, D. A., & Nes, I. F. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-194 · Cited by 83
“the leading causes of nosocomial infections [36,37].”
Acinetobacterinfections: a growing threat for critically ill patients
Falagas, M. E., Karveli, E. A., Siempos, I. Ι., & Vardakas, K. Z. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807009478 · Cited by 82
“03/95–11/02 Wisplinghoff [11] Surveillance 49 cities (SCOPE project) USA BSI n.”
BackgroundChua, T., Moore, C. L., Perri, M. B., Donabedian, S. M., Masch, W. R., Vager, D. L., Davis, S. L., Lulek, K., Zimnicki, B., & Zervos, M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00154-08 · Cited by 86
Ibrahim, A. S., Spellberg, B. J., Avanesian, V., Fu, Y., & Edwards, J. E. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.3039-3041.2006 · Cited by 80
“Disseminated candidiasis typically occurs after multiple weeks of hospitalization (15), affording the opportunity to intervene prior to disease onset.”
BackgroundMartínez, J. A., Soto, S. M., Fàbrega, A., Almela, M., Mensa, J., Soriano, À., Marco, F., de Anta, M. T. J., & Vilà, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.4.1468-1474.2006 · Cited by 81
“3 Urological abnormalities 13 (33) 42 (29) 0.”
BackgroundDavenport, E. K., Call, D. R., & Beyenal, H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03071-14 · Cited by 94
“For example, the pgaABCD gene cluster that is responsible for the production of poly- -(1-6)-N-acetylg-”
BackgroundSiwek, A., Stefańska, J., Dzitko, K., & Ruszczak, A. (2012) · Journal of Molecular Modeling · doi:10.1007/s00894-012-1420-5 · Cited by 96
“Candida species are the fourth most common pathogens isolated from patients with nosocomial bloodstream infections in the United States and the sixth in Europe [7–9].”
BackgroundUncommon opportunistic yeast bloodstream infections from Qatar
Taj‐Aldeen, S. J., Abdulwahab, A., Kolecka, A., Deshmukh, A., Meis, J. F. G. M., & Boekhout, T. (2014) · Medical Mycology · doi:10.1093/mmycol/myu016 · Cited by 89
“The incidence of fungemia is growing and has dramatically increased during the past two decades [3–6].”
BackgroundDelattin, N., De Brucker, K., Vandamme, K., Meert, E., Marchand, A., Chaltin, P., Cammue, B. P. A., & Thevissen, K. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt449 · Cited by 80
Sellam, A., Askew, C., Epp, E., Tebbji, F., Mullick, A., Whiteway, M., & Nantel, A. (2010) · Eukaryotic Cell · doi:10.1128/ec.00325-09 · Cited by 81
“Candida albicans is an opportunistic pathogen responsible for various non-life-threatening infections, such as oral thrush and vaginitis, and accounts for more than half of all Candida infections (21, 40).”
BackgroundStuck in the Middle: Fibronectin-Binding Proteins in Gram-Positive Bacteria
Hymes, J. P., & Klaenhammer, T. R. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01504 · Cited by 90
“Pathogenic strains of staphylococci are one of the most common causes of skin and bloodstream infections in the United States (Lowy, 1998; Wisplinghoff et al., 2004; Moran et al., 2005; Tong et al., 2015).”
Zhang, Y., Du, M., Chang, Y., Chen, L., & Zhang, Q. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0231-y · Cited by 81
“Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program.”
BackgroundResultInfluentialLi, Y., Chang, W., Zhang, M., Li, X., Jiao, Y., & Lou, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128693 · Cited by 79
“Candida species are the fourth most common pathogenic fungus causing nosocomial bloodstream infections in the United States [1].”
BackgroundZhao, Y., Park, S., Kreiswirth, B. N., Ginocchio, C. C., Veyret, R., Laayoun, A., Troesch, A., & Perlin, D. S. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02230-08 · Cited by 80
“Wisplinghoff and colleagues reported that polymicrobial infection constituted 13% of all episodes of nosocomial BSIs in the United States (47), which is associated with higher mortality than monomicrobial BSI and tends to be more resistant to empirical therapy.”
BackgroundInfluentialThe Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future
Tso, G. H. W., Reales-Calderon, J. A., & Pavelka, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00897 · Cited by 78
“Candidiasis (caused by Candida species) is the most common opportunistic fungal infection and the fourth most common nosocomial bloodstream infection (6, 7).”
BackgroundAngioinvasive fungal infections impacting the skin
Shields, B. E., Rosenbach, M. A., Brown‐Joel, Z. O., Berger, A. P., Ford, B. A., & Wanat, K. A. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.04.059 · Cited by 87
Neutrophil-Mediated Inhibition of Proinflammatory Cytokine Responses
Gresnigt, M. S., Joosten, L. A. B., Verschueren, I., van der Meer, J. W. M., Netea, M. G., Dinarello, C. A., & van de Veerdonk, F. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103551 · Cited by 80
Fluconazole Assists Berberine To Kill Fluconazole-Resistant Candida albicans
Li, D.-D., Xu, Y., Zhang, D.-Z., Quan, H., Mylonakis, E., Hu, D.-D., Li, M.-B., Zhao, L.-X., Zhu, L.-H., Wang, Y., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00499-13 · Cited by 78
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it
LASTOURS, V. D., Laouenan, C., Royer, G., Carbonnelle, É., Lepeule, R., Esposito‐Farèse, M., Clermont, O., Duval, X., Fantin, B., Mentré, F., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa161 · Cited by 81
Epitope Shaving Promotes Fungal Immune Evasion
Childers, D. S., Avelar, G. M., Bain, J. M., Pradhan, A., Larcombe, D. E., Netea, M. G., Erwig, L. P., Gow, N. A. R., & Brown, A. J. P. (2020) · mBio · doi:10.1128/mbio.00984-20 · Cited by 80
“albicans is an obligate commensal of warm-blooded animals that causes opportunistic mucosal and systemic infections in immunocompromised patients and other susceptible populations, including individuals requiring abdominal surgery or long-term intensive care (3).”
Risks and Challenges of Implantable Cardioverter-Defibrillators in Young Adults
Sherrid, M. V., & Daubert, J. P. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.10.001 · Cited by 84
Yu, F., Li, T., Huang, X., Xie, J., Xu, Y., Tu, J., Qin, Z., Parsons, C. H., Wang, J., Hu, L., et al. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.08.015 · Cited by 82
“aureus is the leading cause of BSI in the majority of developed countries (Wisplinghoff et al., 2004).”
BackgroundSpellberg, B. J., Ibrahim, A. S., Avenissian, V., Filler, S. G., Myers, C. L., Fu, Y., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.6191-6193.2005 · Cited by 78
“Furthermore, disseminated candidiasis typically occurs after multiple weeks of hospitalization (20), enabling the opportunity for prophylactic vaccination prior to disease onset.”
BackgroundEndocarditis Due to Vancomycin-Resistant Enterococci: Case Report and Review of the Literature
Stevens, M. P., & Edmond, M. B. (2005) · Clinical Infectious Diseases · doi:10.1086/444459 · Cited by 78
“When patients undergoing dialysis develop nosocomial enterococcal bloodstream infection, 75% of the cases are due to vancomycin-resistant isolates [1].”
BackgroundSelf-citationBeyond conventional antibiotics — New directions for combination products to combat biofilm
Bayramov, D. F., & Neff, J. A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.010 · Cited by 87
Lalani, T., Federspiel, J. J., Boucher, H. W., Rude, T. H., Bae, I.-G., Rybak, M. J., Tonthat, G. T., Corey, G. R., Stryjewski, M. E., Sakoulas, G., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00905-08 · Cited by 77
“001† Surgery in prior 30 days 7 (30) 29 (45) 0.”
BackgroundWu, P.-F., Liu, W.-L., Hsieh, M.-H., Hii, I.-M., Lee, Y.-L., Lin, Y.-T., Ho, M.-W., Liu, C.-E., Chen, Y.-H., & Wang, F.-D. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.74 · Cited by 77
She, R. C., & Bender, J. M. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.027409 · Cited by 81
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT
Scarborough, M., Li, H. K., Rombach, I., Zambellas, R., Walker, A. S., McNally, M., Atkins, B., Kümin, M., Lipsky, B. A., Hughes, H., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23380 · Cited by 75
Epidemiology, Incidence and Risk Factors for Invasive Candidiasis in High-Risk Patients
Concia, E., Azzini, A. M., & Conti, M. (2009) · Drugs · doi:10.2165/11315500-000000000-00000 · Cited by 88
van de Veerdonk, F. L., Joosten, L. A. B., Devesa, I., Mora‐Montes, H. M., Kanneganti, T., Dinarello, C. A., van der Meer, J. W. M., Gow, N. A. R., Kullberg, B. J., & Netea, M. G. (2009) · The Journal of Infectious Diseases · doi:10.1086/597274 · Cited by 77
“Candida species are among the most common nosocomial bloodstream pathogens in the United States and Europe [1, 2], and candidemia is associated with a high crude mortality rate of 40% [3, 4].”
BackgroundAssociation between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone Usage
McKinnell, J. A., Kunz, D. F., Chamot, E., Patel, M., Shirley, R. M., Moser, S. A., Baddley, J. W., Pappas, P. G., & Miller, L. G. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/666331 · Cited by 81
Salm, F., Deja, M., Gastmeier, P., Kola, A., Hansen, S., Behnke, M., Gruhl, D., & Leistner, R. (2016) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-016-0157-9 · Cited by 79
“aeruginosa are among the most commonly-found organisms which cause nosocomial infections in intensive care units [12, 13, 18, 21].”
Invasive Fungal Infections in the Intensive Care Unit
Ostrosky-Zeichner, L., & Al-Obaidi, M. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.005 · Cited by 76
“Attributable mortality can be up to 40%.(2,3) The main species of Candida that are found to cause IC are Candida albicans, Candida glabrata, Candida parapsilosis, Candida krusei, and Candida tropicalis.”
BackgroundAssessment of herbal drugs for promising anti-Candida activity
Soliman, S. S. M., Semreen, M. H., El‐Keblawy, A. A., Abdullah, A., Uppuluri, P., & Ibrahim, A. S. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1760-x · Cited by 82
“ANOVA: One-way analysis of variance; BSA: Bovine serum albumin; C. albicans: Candida albicans; CC50: Cytotoxic concentration of the extracts to cause death to 50% of viable cells; CFU: Colony-forming unit; CLSI: Clinical and Laboratory Standards Institute; DPBS: Dulbecco’s phosphate-buffered saline; ICU: Intensive car…”
BackgroundYehya, A., Ezzeddine, Z., Chakkour, M., Dhaini, Z., Saba, M. S. B., Saba, A. S. B., Nohra, L., Nassar, N. B., Yassine, M., Bahmad, H. F., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1565965 · Cited by 93
Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital
Muñóz, P., Giannella, M., Fanciulli, C., Guinea, J., Valerio, M., Rojas, L., Rodríguez‐Créixems, M., & Bouza, E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03338.x · Cited by 93
“Candida species now rank fourth in the USA and sixth in Europe among causes of nosocomial bloodstream infection (BSI) [1–3].”
BackgroundStamper, P. D., Cai, M., Lema, C. A., Eskey, K., & Carroll, K. C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01458-07 · Cited by 76
“Although not observed in United States hospitals until 1987 (26), vancomycin-resistant enterococci (VRE) are a clinical problem that, as predicted, account for an ever-increasing proportion of the enterococcal infections in United States hospitals (3, 10, 35).”
BackgroundKarlsson, A. J., Pomerantz, W. C. K., Neilsen, K. J., Gellman, S. H., & Palecek, S. P. (2009) · ACS Chemical Biology · doi:10.1021/cb900093r · Cited by 84
Mukherjee, P. K., Long, L. A., Kim, H., & Ghannoum, M. A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.030 · Cited by 83
“Moreover, mortalty associated with invasive candidiasis is unacceptably high and pproaches 40% [5–9].”
BackgroundGentamicin induces efaA expression and biofilm formation in Enterococcus faecalis
Kafil, H. S., Mobarez, A. M., Moghadam, M. F., Hashemi, Z. S., & Yousefi, M. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.12.008 · Cited by 92
Norris, L. B., Kablaoui, F., Brilhart, M. K., & Bookstaver, P. B. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.06.013 · Cited by 80
An unappreciated role for neutrophil-DC hybrids in immunity to invasive fungal infections
Fites, J. S., Gui, M., Kernien, J. F., Negoro, P. E., Dagher, Z., Sykes, D. B., Nett, J. E., Mansour, M. K., & Klein, B. S. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007073 · Cited by 86
“Invasive fungal infections are a leading cause of death in cancer and transplant patients [20– 25], and in patients requiring intensive care [18].”
BackgroundCandida albicans biofilm formation and its clinical consequences
Uppuluri, P., Pierce, C. G., & López-Ribot, J. L. (2009) · Future Microbiology · doi:10.2217/fmb.09.85 · Cited by 76
“A variety of biomaterials used in clinical practice are able to support biofilm formation by Candida and, ironically, the increase in candidiasis in recent years (now the third to fourth most common nosocomial infection in US hospitals and abroad) has been virtually concomitant with the increase in use of a broad rang…”
BackgroundSader, H. S., Watters, A. A., Fritsche, T. R., & Jones, R. N. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-29 · Cited by 88
“The SCOPE project report showed a significant increase in the proportion of S. aureus isolates resistant to methicillin among patients in ICUs from 1995 to 2001 (22% vs. 57%; P 5 ].”
BackgroundShahcheraghi, F., Nikbin, V. S., & Feizabadi, M. M. (2009) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0880 · Cited by 75
“2,13,10,18 Acquired resistance due to mutations triggering intrinsic resistance mechanisms ( i.e ., AmpC) and = or acquisition of additional b -lactamase by horizontal gene transfer have also been reported.”
Bacterial–Platelet Interactions: Virulence Meets Host Defense
Yeaman, M. R. (2010) · Future Microbiology · doi:10.2217/fmb.09.112 · Cited by 78
“aureus bacteremia and endocarditis (up to 40%), even with the most contemporary antibiotic therapy [210–217].”
BackgroundManagement of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy
Bassetti, M., Taramasso, L., Giacobbe, D. R., & Pelosi, P. P. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.36 · Cited by 92
Interindividual variability and intraindividual stability of oral fungal microbiota over time
Monteiro-da-Silva, F., Araujo, R., & Sampaio-Maia, B. (2014) · Medical Mycology · doi:10.1093/mmy/myu027 · Cited by 75
“, which continue to be the fourth most common microorganism recovered in bloodstream infections in the United States [23], while Aspergillus spp.”
BackgroundBuchan, B. W., Allen, S., Burnham, C.-A. D., McElvania TeKippe, E., Davis, T., Levi, M., Mayne, D., Pancholi, P., Relich, R. F., Thomson, R., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03108-14 · Cited by 75
Mixed bloodstream infections involving bacteria and Candida spp.
Bouza, E., Burillo, A., Muñoz, P., Guinea, J., Marín, M., & Rodríguez-Créixems, M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt099 · Cited by 74
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.